EVEREST MEDICINES
LIVE

Serial Number

98977528

Owner

Everest Medicines (Singapore) Pte. Ltd.

Attorney

Khanh T. Glatzel

First Use Date

Feb 20, 2025

Filing Date

Feb 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EVEREST MEDICINES Trademark

Serial Number: 98977528

EVEREST MEDICINES is a trademark filed by Everest Medicines (Singapore) Pte. Ltd. on February 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Everest Medicines (Singapore) Pte. Ltd. (6 trademarks)

30 Cecil Street #19-08 Prudential Tower
Singapore 049712 , SG

Entity Type: 24

Trademark Details

Filing Date

February 22, 2024

Registration Date

Not Registered

First Use Anywhere

February 20, 2025

First Use in Commerce

February 20, 2025

Published for Opposition

December 17, 2024

Goods & Services

Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for health care, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal.

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 17, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 17, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 24, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 24, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 24, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 24, 2026 SUPC
DIVISIONAL PROCESSING COMPLETE
Feb 24, 2026 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 13, 2026 AITU
USE AMENDMENT FILED
Aug 8, 2025 IUAF
DIVISIONAL REQUEST RECEIVED
Aug 8, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 8, 2025 ERTD
TEAS STATEMENT OF USE RECEIVED
Aug 8, 2025 EISU
SOU TEAS EXTENSION RECEIVED
Aug 8, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 19, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 24, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 24, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 11, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2024 NWOS
NEW APPLICATION ENTERED
Feb 22, 2024 NWAP